The effect of dopamine on the appropriate time of urination in oliguric patients

Evaluation of the effect of dopamine on the appropriate time of urination in oliguric patients.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011513366N6

Enrollment

120

Registered

2017-10-05

Start date

2016-10-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oliguria. Anuria and oliguria

Interventions

Intervention 1: Intervention group : Dopamine at a dose of 3 microgram/kg per minutes until improvement of oliguria. Intervention 2: Control group :Routine classical drug therapy(Fluid therapy with no

Treatment - Drugs

Intervention group : Dopamine at a dose of 3 microgram/kg per minutes until improvement of oliguria.

Control group :Routine classical drug therapy(Fluid therapy with normal saline) until improvement of oliguria.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterion: acute kidney failure. Exclusion criteria : chronic underlying disease or malignancy; consuming another concurrent drug

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The proper disposal of urine and oliguric recovery. Timepoint: Before and after treatment. Method of measurement: questionnaire.	—

Secondary

Measure	Time frame
Electrolyte disturbances and kidney function. Timepoint: Before and after treatment. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Parsa Yousefi

Arak University of Medical Sciences

parsayousefichaijan@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026